Recursion ipo

Author: csqr

August undefined, 2024

WebDec 17, 2024 · When Recursion Pharmaceutical went public at $18/share back in April, the stock immediately popped up to almost $36/share, a nice double for those lucky enough … WebMar 28, 2024 · Recursion is the clinical-stage biotechnology company industrializing drug discovery by decoding biology. Enabling its mission is the Recursion OS, a platform built …

Recursion Raises $436 Million in Upsized IPO to Advance Rare …

WebMar 22, 2024 · Recursion Pharmaceuticals Inc. has filed for an initial public offering, seeking to sell $100 million worth of shares although that figure is often a placeholder used to … WebIncluding the underwriters’ option of 3.6 million shares, Recursion sold 27.878 million shares at $18/share, raising nearly $502 million in the process (before IPO expenses). However, Recursion shares opened at $26.32 when actual trading began on April 16th, not at $18, a nearly 50% pop. And as of market close today, Recursion stock was priced at … minghui sewing machine price

Buy WalkMe Stock If Revenue Growth Tops 40% - Forbes

WebDec 17, 2024 · You can see how Recursion’s IPO in April starts at the offering price of 18 and ended much higher. It’s a hot biotech stock, you can see it. MORE FROM FORBES ADVISOR Best Tax Software Of 2024... Webhttp://www.recursion.com: View Prospectus: Recursion Pharmaceuticals: Financial Information: Market Cap: $2650.47mil: Revenues: $3.96 mil (last 12 months) Net Income … WebJun 15, 2024 · Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering. Our goal is... most accurate life prediction free

Recursion Pharma is Going Public - Silicon Slopes Newsroom

Recursion ipo

Recursion Pharmaceuticals Announces Pricing of Initial Public …

WebMar 22, 2024 · Recursion Pharmaceuticals, a Phase 2-ready biotech using machine learning to develop therapies for various indications, filed on Monday with the SEC to raise up to … WebJun 17, 2024 · 33 months have passed since I spoke with Sweary and on June 16, WalkMe went public. After going out at $31 a share, the stock lost 7.1% of its value and ended its first day of trading with a ...

Did you know?

WebApr 13, 2024 · Recursion Pharmaceuticals IPO Recursion Pharmaceuticals is going bigger than expected in its initial public offering. After initially indicating it intended to raise $100 million in its Nasdaq debut, the Salt Lake City-based company will now look at bringing in approximately $306 million. WebApr 16, 2024 · Salt Lake City-based Recursion’s shares closed Friday at $31.30, giving Recursion a market value of more than $5 billion. It sold about 24 million shares on …

WebApr 16, 2024 · About Recursion. Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, … WebRecursion is an Equal Opportunity Employer that values diversity and inclusion. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal ...

WebApr 21, 2024 · SALT LAKE CITY, April 21, 2024 /PRNewswire/ -- Recursion Pharmaceuticals, Inc. ("Recursion" or "we") announced the closing on April 20, 2024 of its initial public … WebAug 17, 2024 · Increased visibility of Recursion in the nascent space of AI-powered drug discovery ahead of their IPO (NASDAQ: RXRX); directed …

WebApr 16, 2024 · Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal...

WebApr 27, 2024 · IPO: Recursion Pharmaceuticals Leverages Therapeutics Discovery With Machine Learning April 27, 2024 by Staff Twitter Recursion Pharmaceuticals Inc. uses machine learning to hunt for new therapies. The company raised $436 million in an upsized initial public offering priced at the top of a marketed range. ming-hui chen university of connecticutWebThe Recursion Data Universe: As of March 22, 2024, our Recursion Data Universe contained nearly eight petabytes of highly relatable biological and chemical data spanning multiple different data modalities. The size of the Recursion Data Universe has grown more than threefold since 2024 and has continued to grow at an accelerating rate. For ... minghui li china university of petroleumWebApr 16, 2024 · Recursion Pharmaceuticals Inc., which uses machine learning to hunt for new therapies, raised $436 million in an upsized initial public offering priced at the top of a … most accurate load for 223 remingtonWebRecursion Pharmaceuticals has raised a total of $615.4M in funding over 17 rounds. Their latest funding was raised on Oct 25, 2024 from a Post-IPO Equity round. Recursion … minghung cho facebookWebApr 13, 2024 · Recursion Pharmaceuticals has set terms for a major $306 million IPO as the artificial intelligence biotech eyes a $3 billion valuation. Recursion Pharmaceuticals has … most accurate long range 308 rifleWebMar 23, 2024 · Recursion Pharmaceuticals filed its S-1 paperwork late Monday, coming about six months after completing a $239 million Series D round and securing a deal with Bayer worth up to $1... most accurate literal bible translationWebApr 13, 2024 · Recursion is nearly ready to make its public debut, and the biotech set out what the potential raise might look like Monday. Recursion set its IPO terms, planning to raise $306 million by offering ... most accurate light pollution map